These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38397773)

  • 1. SARS-CoV-2 Spike Protein Stimulates Macropinocytosis in Murine and Human Macrophages via PKC-NADPH Oxidase Signaling.
    Ahn W; Burnett FN; Pandey A; Ghoshal P; Singla B; Simon AB; Derella CC; A Addo S; Harris RA; Lucas R; Csányi G
    Antioxidants (Basel); 2024 Jan; 13(2):. PubMed ID: 38397773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages.
    Satta S; Meng Z; Hernandez R; Cavallero S; Zhou T; Hsiai TK; Zhou C
    Theranostics; 2022; 12(6):2639-2657. PubMed ID: 35401811
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 hijacks macropinocytosis to facilitate its entry and promote viral spike-mediated cell-to-cell fusion.
    Zhang YY; Liang R; Wang SJ; Ye ZW; Wang TY; Chen M; Liu J; Na L; Yang YL; Yang YB; Yuan S; Yin X; Cai XH; Tang YD
    J Biol Chem; 2022 Nov; 298(11):102511. PubMed ID: 36259516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nox2-Mediated PI3K and Cofilin Activation Confers Alternate Redox Control of Macrophage Pinocytosis.
    Ghoshal P; Singla B; Lin H; Feck DM; Cantu-Medellin N; Kelley EE; Haigh S; Fulton D; Csányi G
    Antioxid Redox Signal; 2017 Jun; 26(16):902-916. PubMed ID: 27488058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant S1 protein with hFc for analysis of SARS-CoV-2 adsorption and evaluation of drugs that inhibit entry into VERO E6 cells.
    Couto JCM; Vidal T; Decker ER; Santurio JM; Mello CF; Pillat MM
    Immunol Lett; 2023 Nov; 263():105-112. PubMed ID: 37683695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of spike proteins on angiotensin converting enzyme 2 (ACE2).
    Bejoy J; Williams CI; Cole HJ; Manzoor S; Davoodi P; Battaile JI; Kaushik A; Nikolaienko SI; Brelidze TI; Gychka SG; Suzuki YJ
    Arch Biochem Biophys; 2023 Oct; 748():109769. PubMed ID: 37769892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.
    Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J
    Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
    Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.
    Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
    Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction.
    Eka Saputri M; Aisyah Rahmalia Effendi S; Nadila R; Azzam Fajar S; Damajanti Soejoedono R; Handharyani E; Nadia Poetri O
    Int Immunopharmacol; 2022 Nov; 112():109280. PubMed ID: 36183680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor.
    Hameed NS; Arif IS; Al-Sudani BT
    J Adv Pharm Technol Res; 2023; 14(3):185-190. PubMed ID: 37692001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein.
    Zhang L; Zhang Y; Qin X; Jiang X; Zhang J; Mao L; Jiang Z; Jiang Y; Liu G; Qiu J; Chen C; Qiu F; Zou Z
    Crit Care; 2022 Jun; 26(1):171. PubMed ID: 35681221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients.
    Wang C; Xie J; Zhao L; Fei X; Zhang H; Tan Y; Nie X; Zhou L; Liu Z; Ren Y; Yuan L; Zhang Y; Zhang J; Liang L; Chen X; Liu X; Wang P; Han X; Weng X; Chen Y; Yu T; Zhang X; Cai J; Chen R; Shi ZL; Bian XW
    EBioMedicine; 2020 Jul; 57():102833. PubMed ID: 32574956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein.
    Romero MJ; Yue Q; Singla B; Hamacher J; Sridhar S; Moseley AS; Song C; Mraheil MA; Fischer B; Zeitlinger M; Chakraborty T; Fulton D; Gan L; Annex BH; Csanyi G; Eaton DC; Lucas R
    Front Immunol; 2023; 14():1241448. PubMed ID: 37638055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRPV2-spike protein interaction mediates the entry of SARS-CoV-2 into macrophages in febrile conditions.
    Xu J; Yang Y; Hou Z; Jia H; Wang Y
    Theranostics; 2021; 11(15):7379-7390. PubMed ID: 34158856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.